Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdds a 2018 U.S. NIH Grant/Contract funding line and updates the page revision from v3.6.5 to v3.6.6, reflecting administrative record updates.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, indicating the page has been updated to a newer revision.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.6.4 has been added, replacing the previous Revision: v3.6.3. This indicates a page update that does not modify the study details or core content presented to users.SummaryDifference0.0%

- Check64 days agoChange DetectedA new page revision v3.6.3 was added, replacing the prior v3.6.2.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.6.2 is now displayed, replacing the previous v3.6.0. This indicates a minor maintenance/version update to the page rather than a change to the study information.SummaryDifference0.0%

- Check85 days agoChange DetectedRecruitment status updated to indicate enrollment is closed, signaling that the study is not currently seeking participants. The page now reflects that participant enrollment has ended, informing visitors that no new participants can join at this time.SummaryDifference0.4%

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.